Effect of Baricitinib and Adalimumab in Reducing Pain and Improving Function in Patients with Rheumatoid Arthritis in Low Disease Activity: Exploratory Analyses from RA-BEAM

Patients with rheumatoid arthritis (RA) may experience residual pain and functional impairment despite good control of disease activity. This study compared improvements in pain and physical function in patients with well-controlled RA after 24 weeks’ treatment with baricitinib, adalimumab or placeb...

Descripción completa

Detalles Bibliográficos
Autores principales: Fautrel, Bruno, Kirkham, Bruce, Pope, Janet E., Takeuchi, Tsutomu, Gaich, Carol, Quebe, Amanda, Zhu, Baojin, de la Torre, Inmaculada, De Leonardis, Francesco, Taylor, Peter C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6780319/
https://www.ncbi.nlm.nih.gov/pubmed/31492040
http://dx.doi.org/10.3390/jcm8091394

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6780319/
https://www.ncbi.nlm.nih.gov/pubmed/31492040
http://dx.doi.org/10.3390/jcm8091394

Ejemplares similares